Alfred King-Yin Lam1, Kate Ong, Yik-Hong Ho. 1. Discipline of Pathology, Griffith Medical School, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia. a.lam@griffith.edu.au
Abstract
BACKGROUND: The clinicopathological roles and relationships of hTERT, p21 and p53 proteins have not been studied in depth in colorectal cancer. The aim of the present study is to investigate the clinicopathological roles of expression of hTERT protein expression and its relationship with the expression of p21 and p53 proteins in a large cohort of patients with colorectal adenocarcinoma. MATERIALS AND METHODS: Expressions of hTERT, p21 and p53 proteins were investigated in 188 patients with colorectal adenocarcinomas by immunohistochemistry. The findings were correlated with the clinicopathological features and survival data of colorectal adenocarcinomas. RESULTS: hTERT, p53 and p21 proteins were detected in 63%, 100% and 62% of the patients with colorectal carcinoma. High level of hTERT protein expression was noted in patients with metastases (p = 0.038) and in patients with rectal cancer (p = 0.046). Loss or low level of p21 protein was often noted in non-mucinous colorectal adenocarcinoma when compared with mucinous adenocarcinoma (p = 0.001). Furthermore, p53 expression was more frequently noted in non-mucinous adenocarcinoma (p = 0.001). The level of expression of p21 protein was positively correlated with expression of level of hTERT protein (p = 0.00001). The survival of the patients was related to staging (p = 0.001) and p53 protein expression (p = 0.038) of the tumours. CONCLUSIONS: hTERT protein expression is an indicator of the biological aggressiveness of the cancer. The level of expression of the protein was also related to the distal location and level of p21 expression of the tumours.
BACKGROUND: The clinicopathological roles and relationships of hTERT, p21 and p53 proteins have not been studied in depth in colorectal cancer. The aim of the present study is to investigate the clinicopathological roles of expression of hTERT protein expression and its relationship with the expression of p21 and p53 proteins in a large cohort of patients with colorectal adenocarcinoma. MATERIALS AND METHODS: Expressions of hTERT, p21 and p53 proteins were investigated in 188 patients with colorectal adenocarcinomas by immunohistochemistry. The findings were correlated with the clinicopathological features and survival data of colorectal adenocarcinomas. RESULTS:hTERT, p53 and p21 proteins were detected in 63%, 100% and 62% of the patients with colorectal carcinoma. High level of hTERT protein expression was noted in patients with metastases (p = 0.038) and in patients with rectal cancer (p = 0.046). Loss or low level of p21 protein was often noted in non-mucinous colorectal adenocarcinoma when compared with mucinous adenocarcinoma (p = 0.001). Furthermore, p53 expression was more frequently noted in non-mucinous adenocarcinoma (p = 0.001). The level of expression of p21 protein was positively correlated with expression of level of hTERT protein (p = 0.00001). The survival of the patients was related to staging (p = 0.001) and p53 protein expression (p = 0.038) of the tumours. CONCLUSIONS:hTERT protein expression is an indicator of the biological aggressiveness of the cancer. The level of expression of the protein was also related to the distal location and level of p21 expression of the tumours.
Authors: S Girlando; P Slomp; O Caffo; M Amichetti; R Togni; G Dvornik; L Tomio; E Galligioni; P Dalla Palma; M Barbareschi Journal: Virchows Arch Date: 1999-12 Impact factor: 4.064
Authors: Alfred King-Yin Lam; Vinod Gopalan; Mohammad Reza Nassiri; Kais Kasim; Jayampathy Dissanayake; Johnny Chuek-On Tang; Robert Anthony Smith Journal: Mol Oncol Date: 2011-07-12 Impact factor: 6.603
Authors: Eliane C M Zeestraten; Anne Benard; Marlies S Reimers; Philip C Schouten; Gerrit J Liefers; Cornelis J H van de Velde; Peter J K Kuppen Journal: Biomark Cancer Date: 2013-07-04
Authors: Svetlana O Zhikrivetskaya; Anastasiya V Snezhkina; Andrew R Zaretsky; Boris Y Alekseev; Anatoly V Pokrovsky; Alexander L Golovyuk; Nataliya V Melnikova; Oleg A Stepanov; Dmitry V Kalinin; Alexey A Moskalev; George S Krasnov; Alexey A Dmitriev; Anna V Kudryavtseva Journal: Oncotarget Date: 2017-04-11
Authors: Rahim Golmohammadi; Mohammad J Namazi; Mehdi Nikbakht; Mohammad Salehi; Mohammad H Derakhshan Journal: Gut Liver Date: 2013-04-09 Impact factor: 4.519